Immunotrans-Arterial Chemoembolization (ITACE) in Hepatocellular Carcinoma Patients Treated with anti-EGFR Mab Nimotuzumab Plus Adriamycin. Phase I Clinical Trial, Final Results

Autor:	Eduardo Fermín Hernández, Mauricio Catala Ferrer, Mercedes Cedeño, Jose Jordan, Aymara Fernández Lorente, M. Alvarez, José Carlos Ugarte Suárez, Enrique Rengifo, Tania Crombet Ramos, Milagros Frómeta, Alejandro Valdez, Marcia Samada Suárez, Julio César Hernández Perera, Patricia Lorenzo Luaces, Aliuska Frías, Mayra Ramos-Suzarte
Rok vydání:	2013
Předmět:	Oncology medicine.medical_specialty medicine.drug_class business.industry Phases of clinical research Hematology Monoclonal antibody medicine.disease Internal medicine Hepatocellular carcinoma medicine Carcinoma Nimotuzumab Doxorubicin business medicine.drug
Zdroj:	Annals of Oncology. 24:iv32
ISSN:	0923-7534
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::a932b628b7e77d1b3cba292993fff76f https://doi.org/10.1093/annonc/mdt202.21 Zobrazit plný text záznamu